Guardant Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Guardant Health
GH Stock  USD 114.74  0.01  0.01%   
Guardant Health's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Guardant Health's valuation are provided below:
Gross Profit
575.5 M
Profit Margin
(0.44)
Market Capitalization
14.9 B
Enterprise Value Revenue
17.3388
Revenue
902.6 M
We have found one hundred twenty available fundamental trends for Guardant Health, which can be analyzed and compared to other ratios and to its competitors. Traders should compare all of Guardant Health regular fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year.

Guardant Health Total Revenue

892.36 Million

Check Guardant Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Guardant Health's main balance sheet or income statement drivers, such as Tax Provision of 1.6 M, Net Interest Income of 61.7 M or Interest Income of 64.8 M, as well as many indicators such as Price To Sales Ratio of 5.54, Dividend Yield of 0.0 or Days Sales Outstanding of 88.45. Guardant financial statements analysis is a perfect complement when working with Guardant Health Valuation or Volatility modules.
  
Build AI portfolio with Guardant Stock
Check out the analysis of Guardant Health Correlation against competitors.
For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.

Guardant Health Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.4 B1.7 B892.1 M
Slightly volatile
Short and Long Term Debt Total775.6 M1.5 B515.3 M
Slightly volatile
Other Current Liabilities147.7 M140.7 M52.7 M
Slightly volatile
Total Current Liabilities272.4 M259.4 M97.5 M
Slightly volatile
Other Liabilities6.7 M8.3 M7.4 M
Pretty Stable
Property Plant And Equipment Net179.7 M320.9 M120.4 M
Slightly volatile
Current Deferred Revenue42.8 M40.8 M12.9 M
Slightly volatile
Accounts Payable29.3 M44.3 M19.6 M
Slightly volatile
Cash429.7 M604.4 M279.5 M
Slightly volatile
Non Current Assets Total410.6 M495.1 M255.6 M
Slightly volatile
Non Currrent Assets Other170.7 M162.6 M44.3 M
Slightly volatile
Other Assets44 M41.9 M17 M
Slightly volatile
Long Term Debt845.1 M1.3 B544 M
Slightly volatile
Cash And Short Term Investments856.3 M966 M552.9 M
Slightly volatile
Net Receivables66.9 M126.8 M44.8 M
Slightly volatile
Common Stock Shares Outstanding97.2 M141.2 M65.5 M
Slightly volatile
Short Term Investments426.6 M361.6 M273.4 M
Slightly volatile
Long Term Debt Total1.4 B1.3 B527.1 M
Slightly volatile
Liabilities And Stockholders Equity1.4 B1.7 B892.1 M
Slightly volatile
Non Current Liabilities Total1.7 B1.6 B583.7 M
Slightly volatile
Capital Surpluse1.1 B2 B817.4 M
Slightly volatile
Capital Lease Obligations115.9 M222.5 M75.9 M
Slightly volatile
Inventory85.8 M81.7 M26.9 M
Slightly volatile
Other Current Assets22.4 M38.9 M14.9 M
Slightly volatile
Other Stockholder Equity1.5 B2.8 B958.5 M
Slightly volatile
Total Liabilities2 B1.9 B681.1 M
Slightly volatile
Property Plant And Equipment Gross536.9 M511.3 M169.8 M
Slightly volatile
Short and Long Term Debt563.4 K593.1 K7.4 M
Slightly volatile
Preferred Stock Total Equity374 M575 M365.2 M
Slightly volatile
Total Current Assets978.8 M1.2 B636.4 M
Slightly volatile
Non Current Liabilities Other112.1 M106.8 M28.7 M
Slightly volatile
Short Term Debt35.3 M33.6 M10.3 M
Slightly volatile
Property Plant Equipment106.4 M193.1 M81.7 M
Slightly volatile
Net Working Capital946 M954 M608.4 M
Slightly volatile
Intangible Assets9 M6.1 M9.8 M
Very volatile
Warrants54.5 M65.7 M48.9 M
Slightly volatile
Common Stock Total Equity800900982
Slightly volatile
Deferred Long Term Liabilities6.3 M7.1 M7.7 M
Slightly volatile
Capital Stock800900982
Slightly volatile
Common Stock800900982
Slightly volatile
Good Will2.6 M3 M3.2 M
Slightly volatile

Guardant Health Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income64.8 M61.7 M15.4 M
Slightly volatile
Depreciation And Amortization51.2 M48.7 M18.3 M
Slightly volatile
Interest Expense2.8 M3 M2.8 M
Pretty Stable
Selling General Administrative127.5 M207.1 M84.6 M
Slightly volatile
Selling And Marketing Expenses440.7 M419.7 M145.1 M
Slightly volatile
Total Revenue892.4 M849.9 M275.7 M
Slightly volatile
Gross Profit542.4 M516.6 M165.6 M
Slightly volatile
Other Operating Expenses1.4 B1.4 B500.6 M
Slightly volatile
Research Development204.8 M399.9 M137.9 M
Slightly volatile
Cost Of Revenue349.9 M333.3 M110.1 M
Slightly volatile
Total Operating Expenses519.6 M1 B357.6 M
Slightly volatile
Reconciled Depreciation25.5 M48.7 M17.4 M
Slightly volatile
Preferred Stock And Other Adjustments880 K990 K1.1 M
Slightly volatile

Guardant Health Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation169.5 M161.5 M58.5 M
Slightly volatile
Begin Period Cash Flow1.4 B1.3 B334.9 M
Slightly volatile
Depreciation51.2 M48.7 M18.2 M
Slightly volatile
Capital Expenditures38.4 M40.3 M23.7 M
Slightly volatile
End Period Cash Flow442.5 M724.2 M293.5 M
Slightly volatile
Change To Netincome70.3 M119.9 M50.9 M
Slightly volatile
Dividends Paid10.3 M20.5 M8.5 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio5.545.8419.4691
Pretty Stable
Days Sales Outstanding88.4562.6269.2896
Slightly volatile
Stock Based Compensation To Revenue0.160.170.1514
Slightly volatile
Capex To Depreciation0.90.951.2831
Slightly volatile
EV To Sales6.747.119.5312
Pretty Stable
Inventory Turnover4.964.695.774
Slightly volatile
Days Of Inventory On Hand68.9480.5870.5427
Slightly volatile
Payables Turnover6.338.646.3971
Pretty Stable
Sales General And Administrative To Revenue0.480.280.4144
Pretty Stable
Research And Ddevelopement To Revenue0.460.420.5027
Slightly volatile
Capex To Revenue0.05190.05460.1026
Very volatile
Cash Per Share6.746.167.7613
Pretty Stable
Days Payables Outstanding63.9343.767.0216
Slightly volatile
Income Quality0.720.630.7061
Slightly volatile
Intangibles To Total Assets0.01340.00780.0175
Slightly volatile
Current Ratio5.115.388.411
Very volatile
Receivables Turnover4.06.035.7875
Slightly volatile
Capex Per Share0.290.260.271
Slightly volatile
Revenue Per Share5.695.422.9822
Slightly volatile
Interest Debt Per Share5.419.825.0123
Slightly volatile
Debt To Assets0.850.810.3692
Slightly volatile
Operating Cycle133130138
Slightly volatile
Days Of Payables Outstanding63.9343.767.0216
Slightly volatile
Ebt Per Ebit1.081.131.0202
Pretty Stable
Long Term Debt To Capitalization0.551.030.4657
Slightly volatile
Total Debt To Capitalization1.061.010.4381
Slightly volatile
Quick Ratio4.775.028.1632
Very volatile
Net Income Per E B T1.121.151.027
Slightly volatile
Cash Ratio3.072.13.1675
Pretty Stable
Cash Conversion Cycle95.3511073.5243
Slightly volatile
Days Of Inventory Outstanding68.9480.5870.5427
Slightly volatile
Days Of Sales Outstanding88.4562.6269.2896
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.01.031.1507
Pretty Stable
Fixed Asset Turnover2.553.052.2615
Pretty Stable
Debt Ratio0.850.810.3692
Slightly volatile
Price Sales Ratio5.545.8419.4691
Pretty Stable
Asset Turnover0.470.450.2557
Slightly volatile
Gross Profit Margin0.430.550.3889
Slightly volatile

Guardant Health Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.4 B2.9 B1.9 B
Slightly volatile
Enterprise Value1.4 B2.8 B1.8 B
Slightly volatile

Guardant Fundamental Market Drivers

Guardant Upcoming Events

22nd of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Guardant Health Financial Statements

Investors use fundamental indicators, such as Guardant Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although Guardant Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue40.8 M42.8 M
Total Revenue849.9 M892.4 M
Cost Of Revenue333.3 M349.9 M
Stock Based Compensation To Revenue 0.17  0.16 
Sales General And Administrative To Revenue 0.28  0.48 
Research And Ddevelopement To Revenue 0.42  0.46 
Capex To Revenue 0.05  0.05 
Revenue Per Share 5.42  5.69 
Ebit Per Revenue(0.54)(0.57)

Currently Active Assets on Macroaxis

HITIHigh Tide
HITIHigh Tide
BACBank of America
SSentinelOne
GMGeneral Motors
How To Invest In Guardant
Details
Is Guardant Stock a good investment?
Details
What is Guardant Health's Net Worth?
Details
Largest Health Care Providers & Services Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of Guardant Health Correlation against competitors.
For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.22)
Revenue Per Share
7.27
Quarterly Revenue Growth
0.385
Return On Assets
(0.20)
Return On Equity
(45.84)
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY